SCHEMBL1324799

SCHEMBL1324799

CCCC(Oc1ccc(C(=O)O)c(C)n1)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 4/20 0.49
▸ KMT2A Q03164 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ USP2 O75604 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ DPP4 P27487 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ MMP13 P45452 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1295284 0.82 GPR119 (0.49) GPR119KMT2AMEN1NPSR1USP2
SCHEMBL1295288 0.82 GPR119 (0.49) GPR119KMT2AMEN1NPSR1USP2
SCHEMBL1324797 0.78 MMP13 (0.41) GPR119DPP4MMP13USP30
SCHEMBL1295379 0.77 GPR119 (0.54) GPR119KMT2AMEN1NPSR1USP2
SCHEMBL1295116 0.73 GPR119 (0.49) GPR119KMT2AMEN1NPSR1HPGD
SCHEMBL1295113 0.73 GPR119 (0.49) GPR119KMT2AMEN1NPSR1HPGD
SCHEMBL19329299 0.69 GPR119 (0.59) GPR119KMT2AMEN1NPSR1USP2
SCHEMBL1296046 0.69 GPR119 (0.52) GPR119KMT2AMEN1NPSR1HPGD
SCHEMBL590981 0.69 SLC6A2 (0.55) GPR119HPGDDPP4ALDH1A1KDM4E
SCHEMBL586621 0.69 SLC6A2 (0.45) GPR119NPSR1HPGDDPP4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269734-A1 PIPERIDINYL GPCR AGONISTS PROSIDION LIMITED (GB) 2011-11-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269734-A1 PIPERIDINYL GPCR AGONISTS GPR119, GPR27, GLP1R GPR119 1/4885KMT2A 3441/4885MEN1 4351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback